is all semaglutide compounded semaglutide: What should patients know? The End of Compounded Semaglutide:

In 2019, ESC guidelines recommended the use of SGLT2 inhibitors or GLP-1 RAs as first-line drugs in CV patients at high or very high risk with T2DM who do not receive any glucose-lowering treatment and the addition to current glucose-lowering therapy of SGLT2 inhibitors or GLP-1 RAs in those patients regardless of glucose control (Figure 3),18

According to the company, the serum has been its strongest launch to date in terms of units sold, setting records for both first-day sales and first-week sales, over-delivering on its four-week unit forecast by 10%, and selling out on Sephora.com

& Andrews, S

In that case, you can assure them that the cost of care is an important topic for many patients, and they are not alone in having questions and concerns